Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg |
PDE7A Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg |
Pax2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1228 | Mouse IL 6 Protein (AC1228) | 2 µg |
Interleukin-6 Mouse Recombinant
|
inquiry |
| ACPP-1229 | Mouse Leptin Protein (AC1229) | 200 µg |
Leptin Mouse Recombinant
|
inquiry |
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg |
MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1231 | Prominin 1 Blocking Peptide (AC1231) | 250 µg |
Prominin 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg |
GPCR GPR15 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg |
Galectin 3 Blocking Peptide for Immmunodepletion, Competition Assay
|
inquiry |
| ACPP-1234 | SOX10 Blocking Peptide (AC1234) | 250 µg |
SOX10 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1235 | C1orf187 Blocking Peptide (AC1235) | 250 µg |
C1orf187 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg |
SOX2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg |
CRMP1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg |
LIMK1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1239 | PDE7B Blocking Peptide (AC1239) | 250 µg |
PDE7B Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1240 | PAX5 Blocking Peptide (AC1240) | 250 µg |
PAX5 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.